CN Patent

CN108619107A — 一种含鲁比前列酮的软胶囊及其制备方法

Assigned to Qinghai Pharmaceutical Co Ltd · Expires 2018-10-09 · 8y expired

What this patent protects

本发明公开了一种含鲁比前列酮的软胶囊及其制备方法，所述的胶囊为软弹性胶囊，由囊壳和包含在囊壳内的液体组合物组成，所述液体组合物为鲁比前列酮和适宜的溶剂等组成，囊壳成分由明胶、纯化水、增塑剂、防腐剂、抗氧化剂、遮光剂、着色剂组成。软胶囊崩解时间短、溶出迅速、生物利用度高、剂量准确、易吸收。本发明能够有效提高鲁比前列酮活性成分的稳定性及生物利用度，且制备方法相对简单，易于生产，具有广阔的应用前景。

USPTO Abstract

本发明公开了一种含鲁比前列酮的软胶囊及其制备方法，所述的胶囊为软弹性胶囊，由囊壳和包含在囊壳内的液体组合物组成，所述液体组合物为鲁比前列酮和适宜的溶剂等组成，囊壳成分由明胶、纯化水、增塑剂、防腐剂、抗氧化剂、遮光剂、着色剂组成。软胶囊崩解时间短、溶出迅速、生物利用度高、剂量准确、易吸收。本发明能够有效提高鲁比前列酮活性成分的稳定性及生物利用度，且制备方法相对简单，易于生产，具有广阔的应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN108619107A
Jurisdiction
CN
Classification
—
Expires
2018-10-09
Drug substance claim
No
Drug product claim
No
Assignee
Qinghai Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.